| The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome E Drummond, T Kavanagh, G Pires, M Marta-Ariza, E Kanshin, S Nayak, ... Acta neuropathologica communications 10 (1), 53, 2022 | 78 | 2022 |
| Unique transcriptome patterns of the white and grey matter corroborate structural and functional heterogeneity in the human frontal lobe JD Mills, T Kavanagh, WS Kim, BJ Chen, Y Kawahara, GM Halliday, ... PLoS One 8 (10), e78480, 2013 | 48 | 2013 |
| Regulation of mitochondrial metabolism in murine skeletal muscle by the medium‐chain fatty acid receptor Gpr84 MK Montgomery, B Osborne, AE Brandon, L O'Reilly, CE Fiveash, ... The FASEB Journal 33 (11), 12264, 2019 | 42 | 2019 |
| Compilation of reported protein changes in the brain in Alzheimer’s disease M Askenazi, T Kavanagh, G Pires, B Ueberheide, T Wisniewski, ... Nature Communications 14 (1), 4466, 2023 | 39 | 2023 |
| Tau interactome and RNA binding proteins in neurodegenerative diseases T Kavanagh, A Halder, E Drummond Molecular neurodegeneration 17 (1), 66, 2022 | 39 | 2022 |
| High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation JD Mills, T Kavanagh, WS Kim, BJ Chen, PD Waters, GM Halliday, ... Molecular brain 8, 1-12, 2015 | 39 | 2015 |
| Pathway analysis of the human brain transcriptome in disease T Kavanagh, JD Mills, WS Kim, GM Halliday, M Janitz Journal of Molecular Neuroscience 51, 28-36, 2013 | 19 | 2013 |
| Similar brain proteomic signatures in Alzheimer’s disease and epilepsy D Leitner, G Pires, T Kavanagh, E Kanshin, M Askenazi, B Ueberheide, ... Acta Neuropathologica 147 (1), 27, 2024 | 6 | 2024 |
| 人类阿尔茨海默病脑组织蛋白质组图谱的见解 T Kavanagh, E Drummond 中国神经再生研究 (英文版) 20 (3), 799, 2025 | | 2025 |
| Insights from a proteomic atlas of human Alzheimer’s disease brain tissue T Kavanagh, E Drummond Neural Regeneration Research 20 (3), 799-800, 2025 | | 2025 |
| The pTau217 interactome in human Alzheimer’s disease brain tissue from APOE3 and APOE4 carriers T Kavanagh, J Ponce, M Thierry, B Ueberheide, T Wisniewski, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation K Balcomb, C Johnston, T Kavanagh, GM Halliday, T Wisniewski, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment D Leitner, T Kavanagh, E Kanshin, K Balcomb, G Pires, M Thierry, ... Acta Neuropathologica 148 (1), 9, 2024 | | 2024 |
| F37. STUDY OF ALTERNATIVE SPLICING EVENTS IN MULTIPLEX BIPOLAR FAMILIES M Martínez-Jiménez, IG Ortiz, T Kavanagh, L Marshall, A Heath, ... European Neuropsychopharmacology 75, S240, 2023 | | 2023 |
| F45. RNA SEQUENCING ANALYSES IN BIPOLAR MULTIPLEX FAMILIES POINT TO NOVEL GENES AND DYSREGULATED PATHWAYS IG Ortiz, MM Jiménez, T Kavanagh, L Marshall, A Heath, JJL Lozano, ... European Neuropsychopharmacology 75, S245, 2023 | | 2023 |
| Meta-analysis of proteomics studies in Alzheimer’s disease post-mortem human brain tissue T Kavanagh, E Drummond AAIC Neuroscience Next, 2020 | | 2020 |
| The role of alternative splicing and long non-coding RNAs in parkinson’s disease T Kavanagh UNSW Sydney, 2018 | | 2018 |
| THE ROLE OF NOVEL TAU INTERACTOR SECERNIN-1 IN ALZHEIMER’S DISEASE AND FRONTOTEMPORAL DEMENTIA A Halder, T Kavanagh, G Halliday, E Drummond | | |
| RNA BINDING PROTEINS ARE ENRICHED IN TAU INTERACTIONS IN DISEASE T Kavanagh, A Halder, G Halliday, E Drummond | | |
